This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kreidenweiss, A.
Right arrow Articles by Kremsner, P. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kreidenweiss, A.
Right arrow Articles by Kremsner, P. G.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, April 2006, p. 1535-1537, Vol. 50, No. 4
0066-4804/06/$08.00+0     doi:10.1128/AAC.50.4.1535-1537.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Antimalarial Activity of a Synthetic Endoperoxide (RBx-11160/OZ277) against Plasmodium falciparum Isolates from Gabon

Andrea Kreidenweiss,1,2,{dagger} Benjamin Mordmüller,1,2,{dagger}* Sanjeev Krishna,1,3 and Peter G. Kremsner1,2

Medical Research Laboratory, Albert Schweitzer Hospital, Lambaréné, Gabon,1 Department of Parasitology, University of Tübingen, Germany,2 Division of Cellular and Molecular Medicine, Centre for Infection, St. George's, University of London, Cranmer Terrace, London, SW17 0RE, Great Britain3

Received 11 November 2005/ Returned for modification 28 January 2006/ Accepted 9 February 2006

OZ277 is a newly developed, fully synthetic endoperoxide antimalarial that we tested against field isolates from Gabon. A comparison of activities of OZ277 with artesunate, mefloquine, and chloroquine showed OZ277 to be highly active against all parasite isolates. Artesunate and mefloquine also showed potent antiparasitic activity, but all isolates were chloroquine resistant.


* Corresponding author. Mailing address: Department of Parasitology, University of Tübingen, Wilhelmstr. 27, D-72074 Tübingen, Germany. Phone: 49 7071 2980240. Fax: 49 7071 295189. E-mail: benjamin.mordmueller{at}uni-tuebingen.de.

{dagger} These two authors contributed equally to this work.


Antimicrobial Agents and Chemotherapy, April 2006, p. 1535-1537, Vol. 50, No. 4
0066-4804/06/$08.00+0     doi:10.1128/AAC.50.4.1535-1537.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Ramharter, M., Kurth, F. M., Belard, S., Bouyou-Akotet, M. K., Mamfoumbi, M. M., Agnandji, S. T., Missinou, M. A., Adegnika, A. A., Issifou, S., Cambon, N., Heidecker, J. L., Kombila, M., Kremsner, P. G. (2007). Pharmacokinetics of two paediatric artesunate mefloquine drug formulations in the treatment of uncomplicated falciparum malaria in Gabon. J Antimicrob Chemother 60: 1091-1096 [Abstract] [Full Text]  
  • OSORIO, L., MURILLO, C., APONTE, S., MAYAGAYA, V., SCHEURER, C., BRUN, R., MATILE, H., WITTLIN, S. (2007). IN VITRO SUSCEPTIBILITY OF P. FALCIPARUM POPULATIONS FROM COLOMBIA AND TANZANIA TO A NEW SYNTHETIC PEROXIDE (OZ277). Am J Trop Med Hyg 76: 1024-1026 [Abstract] [Full Text]  
  • Uhlemann, A.-C., Wittlin, S., Matile, H., Bustamante, L. Y., Krishna, S. (2007). Mechanism of Antimalarial Action of the Synthetic Trioxolane RBX11160 (OZ277). Antimicrob. Agents Chemother. 51: 667-672 [Abstract] [Full Text]